Barbara Ryan - 09 Mar 2026 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Austin Charette as Attorney-in-Fact for Barbara Ryan
Issuer symbol
INKT
Transactions as of
09 Mar 2026
Net transactions value
-$22,052
Form type
4
Filing time
11 Mar 2026, 18:22:03 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ryan Barbara Director 149 FIFTH AVENUE, SUITE 500, NEW YORK By: /s/ Austin Charette as Attorney-in-Fact for Barbara Ryan 11 Mar 2026 0001827169

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Sale $2,034 -200 -0.91% $10.17 21,706 09 Mar 2026 Direct F1
transaction INKT Common Stock Sale $4,585 -300 -1.4% $15.28 21,406 10 Mar 2026 Direct F1
transaction INKT Common Stock Sale $7,783 -500 -2.3% $15.57 20,906 10 Mar 2026 Direct F1
transaction INKT Common Stock Sale $7,650 -500 -2.4% $15.30 20,406 10 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.